Banner Image

enterprise-employers

HHS Requires List Price to Be Included in TV Drug Advertisements - Drug News of Note May 2019

May 31, 2019 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations. This month, we highlight HHS requirement that list price be included in TV ads, FDA approval of Zolgensma, and Gilead Sciences agreement to donate PrEP medications to a government effort to reduce HIV rates.
Read more ▸▸

Prescription Drug News of Note - April 2019

May 1, 2019 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations. This month, we highlight CMS' targeting of manufacturer coupons, Sanofi's launching of a flat fee program for insulins, and Amazon's initial marketing of PillPack to Amazon Prime members
Read more ▸▸

Prescription Drug News of Note - March 2019

Mar 29, 2019 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations. This month, we highlight news of Louisiana's new Hepatitis C cost containment program, Eli Lilly's new authorized generic insulin, and the FDA's approval of a new Diovan generic.
Read more ▸▸

Prescription Drug News of Note - February 2019

Feb 28, 2019 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations. This month, we have an update on the NASH pipeline, notify on a black box warning for Uloric, a gout medication, and an update on HHS blocking drug rebates for government sponsored plans
Read more ▸▸

Prescription Drug News of Note - January 2019

Jan 31, 2019 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Updated Management Guidelines for AFib | Cancer Rates Continue to Fall | Increased Spending Within Type 1 Diabetes
Read more ▸▸

Prescription Drug News of Note - December 2018

Dec 30, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Oncology biosimilars approved by FDA | Guidance on NASH medication development | January price increases
Read more ▸▸

Prescription Drug News of Note - November 2018

Nov 30, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Generic for MS | New recommendations on HIV therapy | FDA approves new cancer medication with a unique indication
Read more ▸▸

Prescription Drug News of Note - October 2018

Oct 30, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Cholesterol drug price reduction?! New FDA approval on a flu treatment | Comparative results of two MS products | FDA expands indication for Hemophilia medication
Read more ▸▸

Prescription Drug News of Note - September 2018

Oct 1, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: This month includes figures on the prevalence of Diabetes among US adults, new Migraine management products, Vascepa showing reduction in cardiovascular events, and new Hepatitis C generics,.
Read more ▸▸

Prescription Drug News of Note - August 2018

Aug 29, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: This month includes news on FDA approval of a first-of-its-kind peripheral nerve disease (polyneuropathy) therapy, and the latest on Teva's EpiPen generic
Read more ▸▸

Prescription Drug News of Note - July 2018

Jul 31, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: This month includes news on FDA approval of Tibsovo and Nivestym, and highlights positive results from an Alzheimer's trial
Read more ▸▸

How to Make Smarter Decisions About Your Company’s Prescription Drug Spend

Jul 11, 2018 | Trends, Insights & Analysis, Enterprise Employers, Pharmacy Benefit Managers
As pharmacy benefit costs continue to rise, effective PBM management is needed more than ever. TruBid brings transparency and savings to today’s companies.
Read more ▸▸

Prescription Drug News of Note - June 2018

Jun 29, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: This month includes news on FDA approval of marijuana-based seizure medication, thoughts on whether OLUMIANT change inflammatory drug pricing, an analysis of Part D spending on brand drugs, and last but not least, Amazon's acquisition of PillPack.
Read more ▸▸

Prescription Drug News of Note - May 2018

May 31, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

Prescription Drug News of Note - April 2018

Apr 27, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

Prescription Drug News of Note - March 2018

Mar 27, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

Prescription Drug News of Note - February 2018

Feb 27, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: FDA Approvals, Prescription spending trends, and the latest on Albertson's and Rite Aid
Read more ▸▸

2018 Specialty Drug Trends: What Employers Should Expect

Jan 30, 2018 | Trends, Insights & Analysis, Enterprise Employers, Pharmacy Benefit Managers
Specialty drugs are expensive for employers paying for prescription benefit plans. Learn how to lower costs in 2018 with specialty drug management strategies.
Read more ▸▸

Prescription Drug News of Note - January 2018

Jan 26, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: FDA Approves 46 Novel Medications in 2017, Hospitals to Start Their Own Generic Drug Company
Read more ▸▸

PBM Contracts: 7 Terms Employers Need to Know

Jan 12, 2018 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Pharmacy Benefit Managers
PBM contracts can be confusing and packed with jargon. Here’s what employers need to know to navigate their pharmacy benefits.
Read more ▸▸

Your Cheat Sheet for Pharmacy Benefits

Dec 26, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Pharmacy Benefit Managers
Pharmacy benefits can be confusing, with many moving parts. Our cheat sheet breaks down what you need to know to become wiser in the area of pharmacy benefits.
Read more ▸▸

Top 4 Myths of Pharmacy Benefits

Dec 26, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Pharmacy Benefit Managers
When it comes to pharmacy benefits, there's a lot of information out there — and a lot of misinformation. We present and debunk 4 myths about pharmacy benefits.
Read more ▸▸

Pharmacy Carve Out: Why it Makes Sense for Employers

Nov 28, 2017 | Trends, Insights & Analysis, Enterprise Employers, Brokers, Pharmacy Carve Out
Thinking about carving out your company’s pharmacy benefits? Here’s why a pharmacy carve-out might be right for your company.
Read more ▸▸

Prescription Drug News of Note - November 2017

Nov 28, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations... FDA approves Lyrica CR capsules, Imprimis Pharmaceuticals announces alternative to Restasis
Read more ▸▸

What is a Pharmacy Carve Out Plan?

Nov 14, 2017 | Trends, Insights & Analysis, Enterprise Employers, Brokers, Pharmacy Carve Out
Employers are turning to pharmacy carve out plans as a solution to rising prescription drug costs. Here’s your primer on carving out pharmacy benefits.
Read more ▸▸

What Anthem's new PBM, IngenioRx means for Brokers and Employers

Oct 23, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Pharmacy Benefit Managers
Anthem, Inc. announced that it is establishing a new pharmacy benefits manager (PBM) named IngenioRx. What does this mean for employers and brokers?
Read more ▸▸

Prescription Drug News of Note - October 2017

Oct 15, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations to give you an expert take on what you need to know.
Read more ▸▸

Prescription Drug News of Note - September 2017

Sep 11, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations to give you an expert take on what you need to know.
Read more ▸▸

What is a Pharmacy Benefit Manager (PBM) and how Does a PBM Impact the Pharmacy Benefits Ecosystem?

Aug 15, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Pharmacy Benefit Managers
Pharmacy Benefits Managers play an important and often complicated role in the prescription benefits industry. Learn more on the Truveris blog.
Read more ▸▸

Prescription Drug News of Note – August 2017

Aug 1, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Prescription Drug News & Regulations - Employers
A rundown of the latest FDA approvals and regulations from August 2017, with an expert take on what you need to know in the prescription drug industry.
Read more ▸▸

10 Questions Employers Should Be Asking About the Cadillac Tax

Apr 20, 2016 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
The Cadillac Tax is an excise tax levied on employers that provide high-cost health benefit plans to their employees.
Read more ▸▸

What Is A Single Source Generic And How Does It Impact Drug Pricing?

Apr 7, 2016 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Drug Pricing
Before signing up for any new insurance plan, you should familiarize yourself with an often overlooked segment of insurance – your pharmacy benefits plan.
Read more ▸▸